Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 403

Similar articles for PubMed (Select 8882210)

1.

Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.

Eng PA, Morton J, Douglass JA, Riedler J, Wilson J, Robertson CF.

Pediatr Pulmonol. 1996 Feb;21(2):77-83.

PMID:
8882210
2.

Mucus clearance and lung function in cystic fibrosis with hypertonic saline.

Donaldson SH, Bennett WD, Zeman KL, Knowles MR, Tarran R, Boucher RC.

N Engl J Med. 2006 Jan 19;354(3):241-50.

3.

Inhaled hypertonic saline increases sputum expectoration in cystic fibrosis.

Riedler J, Reade T, Button B, Robertson CF.

J Paediatr Child Health. 1996 Feb;32(1):48-50.

PMID:
8652214
4.

A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis.

Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, Belousova EG, Xuan W, Bye PT; National Hypertonic Saline in Cystic Fibrosis (NHSCF) Study Group.

N Engl J Med. 2006 Jan 19;354(3):229-40.

5.

Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis.

Subbarao P, Balkovec S, Solomon M, Ratjen F.

Pediatr Pulmonol. 2007 May;42(5):471-6.

PMID:
17436328
6.

Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis.

Robinson M, Hemming AL, Regnis JA, Wong AG, Bailey DL, Bautovich GJ, King M, Bye PT.

Thorax. 1997 Oct;52(10):900-3.

7.

Predicting response to rhDNase and hypertonic saline in children with cystic fibrosis.

Suri R, Metcalfe C, Wallis C, Bush A.

Pediatr Pulmonol. 2004 Apr;37(4):305-10.

PMID:
15022126
8.

Nebulised hypertonic saline for cystic fibrosis.

Wark PA, McDonald V.

Cochrane Database Syst Rev. 2003;(1):CD001506. Review. Update in: Cochrane Database Syst Rev. 2005;(3):CD001506.

PMID:
12535409
9.

Hypertonic saline treatment of cystic fibrosis.

Taylor LM, Kuhn RJ.

Ann Pharmacother. 2007 Mar;41(3):481-4. Epub 2007 Feb 27. Review.

PMID:
17327291
10.

Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis.

Suri R, Grieve R, Normand C, Metcalfe C, Thompson S, Wallis C, Bush A.

Thorax. 2002 Oct;57(10):841-6.

11.

Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function.

Amin R, Subbarao P, Jabar A, Balkovec S, Jensen R, Kerrigan S, Gustafsson P, Ratjen F.

Thorax. 2010 May;65(5):379-83. doi: 10.1136/thx.2009.125831.

PMID:
20435858
12.

Nebulized hypertonic saline via positive expiratory pressure versus via jet nebulizer in patients with severe cystic fibrosis.

O'Connell OJ, O'Farrell C, Harrison MJ, Eustace JA, Henry MT, Plant BJ.

Respir Care. 2011 Jun;56(6):771-5. doi: 10.4187/respcare.00866. Epub 2011 Feb 11.

13.

Nebulised hypertonic saline for cystic fibrosis.

Wark P, McDonald VM.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD001506. doi: 10.1002/14651858.CD001506.pub3. Review.

PMID:
19370568
14.

Nebulised hypertonic saline for cystic fibrosis.

Wark PA, McDonald V, Jones AP.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD001506. Review. Update in: Cochrane Database Syst Rev. 2009;(2):CD001506.

PMID:
16034863
15.

[Tolerance of two inhaled hypertonic saline solutions in patients with cystic fibrosis].

Máiz Carro L, Lamas Ferreiro A, Ruiz de Valbuena Maiz M, Wagner Struwing C, Gabilondo Álvarez G, Suárez Cortina L.

Med Clin (Barc). 2012 Feb 4;138(2):57-9. doi: 10.1016/j.medcli.2011.02.022. Epub 2011 Apr 20. Spanish.

PMID:
21511313
16.

Efficacy, safety, and local pharmacokinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa.

Lenoir G, Antypkin YG, Miano A, Moretti P, Zanda M, Varoli G, Monici Preti PA, Aryayev NL.

Paediatr Drugs. 2007;9 Suppl 1:11-20.

PMID:
17536871
17.

Safety and tolerability of inhaled hypertonic saline in young children with cystic fibrosis.

Dellon EP, Donaldson SH, Johnson R, Davis SD.

Pediatr Pulmonol. 2008 Nov;43(11):1100-6. doi: 10.1002/ppul.20909.

PMID:
18828160
18.

Nebulised hypertonic saline for cystic fibrosis.

Wark PA, McDonald V.

Cochrane Database Syst Rev. 2000;(2):CD001506. Review. Update in: Cochrane Database Syst Rev. 2003;(1):CD001506.

PMID:
10796798
19.

Comparison of effects of 3 and 7% hypertonic saline nebulization on lung function in children with cystic fibrosis: a double-blind randomized, controlled trial.

Gupta S, Ahmed F, Lodha R, Gupta YK, Kabra SK.

J Trop Pediatr. 2012 Oct;58(5):375-81. doi: 10.1093/tropej/fms004. Epub 2012 Feb 28.

PMID:
22374985
20.

Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial.

Rosenfeld M, Ratjen F, Brumback L, Daniel S, Rowbotham R, McNamara S, Johnson R, Kronmal R, Davis SD; ISIS Study Group.

JAMA. 2012 Jun 6;307(21):2269-77. doi: 10.1001/jama.2012.5214.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk